Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3843835 | Actas Urológicas Españolas | 2012 | 6 Pages |
Abstract
The use of PSATZD cut-offs as a biopsy indication may reduce many unnecessary biopsies without missing most prostate cancer cases in the PSA range of 2.0 to 4.0Â ng/ml.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
A. Janane, F. Hajji, T. Ismail, C. Jawad, J.C. Elondo, Y. Dakka, M. Ghadouane, A. Ameur, M. Abbar, A. Albouzidi,